Vitamin E Intake and Risk of Prostate Cancer: A Meta-Analysis

Overview

Journal Nutrients

Date 2023 Jan 8

PMID 36615673

Authors

Wei Qi Loh

Jiyoung Youn

Wei Jie Seow

Affiliations

Soon will be listed here.

Abstract

Vitamin E is a group of antioxidative tocopherols and tocotrienols that play a potential role in chemoprevention. Studies investigating the association between vitamin E and prostate cancer risk have been conflicting. We identified observational and interventional studies examining the association between vitamin E intake and prostate cancer risk from PubMed, EMBASE and the Cochrane Library. A random-effects model was used to perform a meta-analysis and estimate relative risks (RRs) and the corresponding 95% confidence intervals (CIs) of prostate cancer risk according to vitamin E intake. Subgroup analyses were conducted by study design, sample size, study population characteristics, geographical region, and dose of vitamin E intake. The association between dietary (RR = 0.97; 95% CI = 0.92-1.02) and supplemental (RR = 0.99; 95% CI = 0.94-1.04) vitamin E intake on prostate cancer risk was non-significant. In subgroup analyses, supplemental vitamin E was significantly associated with reduced prostate cancer risk in studies in Europe (RR = 0.81, 95% CI = 0.69-0.97). Overall, this meta-analysis demonstrates little evidence for a beneficial effect of vitamin E intake on prostate cancer risk but suggests that there may be some conditions in which supplements could confer a protective effect on prostate cancer risk.

Citing Articles

Association of composite dietary antioxidant index with high risk of prostate cancer in middle-aged and elderly men: insights from NHANES.

Jin X, Tong W, Sun L, Lu S, Sun P, Li H Front Immunol. 2025; 16:1530174.

PMID: 40040693 PMC: 11876124. DOI: 10.3389/fimmu.2025.1530174.

An untargeted metabolomic analysis of acute AFB1 treatment in liver, breast, and lung cells.

Cao H, Molina S, Sumner S, Rushing B PLoS One. 2025; 20(1):e0313159.

PMID: 39883710 PMC: 11781672. DOI: 10.1371/journal.pone.0313159.

Pandemic-associated food insecurity in northern, coastal Ecuador.

Lee G, Cevallos W, Andrade P, Van Engen A, Uruchima J, Redd C J Hunger Environ Nutr. 2025; 19(6):1261-1276.

PMID: 39872678 PMC: 11771988. DOI: 10.1080/19320248.2023.2301074.

Biochemical mechanisms and molecular interactions of vitamins in cancer therapy.

Aborode A, Onifade I, Olorunshola M, Adenikinju G, Aruorivwooghene I, Femi A Cancer Pathog Ther. 2025; 3(1):3-15.

PMID: 39872372 PMC: 11764782. DOI: 10.1016/j.cpt.2024.05.001.

Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease.

Mao Y, Chen H, Zhu W, Ni S, Luo S, Tang S J Inflamm Res. 2025; 18:883-894.

PMID: 39867947 PMC: 11760270. DOI: 10.2147/JIR.S498340.

References

Traber M . Vitamin E inadequacy in humans: causes and consequences. Adv Nutr. 2014; 5(5):503-14. PMC: 4188222. DOI: 10.3945/an.114.006254. View

Bidoli E, Talamini R, Zucchetto A, Bosetti C, Negri E, Lenardon O . Dietary vitamins E and C and prostate cancer risk. Acta Oncol. 2009; 48(6):890-4. DOI: 10.1080/02841860902946546. View

Arai H, Kono N . α-Tocopherol transfer protein (α-TTP). Free Radic Biol Med. 2021; 176:162-175. DOI: 10.1016/j.freeradbiomed.2021.09.021. View

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

Yang C, Luo P, Zeng Z, Wang H, Malafa M, Suh N . Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols. Mol Carcinog. 2020; 59(4):365-389. PMC: 7255062. DOI: 10.1002/mc.23160. View

Peters U, Littman A, Kristal A, Patterson R, Potter J, White E . Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control. 2007; 19(1):75-87. DOI: 10.1007/s10552-007-9072-y. View

Waniek S, di Giuseppe R, Esatbeyoglu T, Plachta-Danielzik S, Ratjen I, Jacobs G . Vitamin E (α- and γ-Tocopherol) Levels in the Community: Distribution, Clinical and Biochemical Correlates, and Association with Dietary Patterns. Nutrients. 2017; 10(1). PMC: 5793231. DOI: 10.3390/nu10010003. View

Agalliu I, Kirsh V, Kreiger N, Soskolne C, Rohan T . Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiol. 2010; 35(4):353-61. DOI: 10.1016/j.canep.2010.11.002. View

Key T, Appleby P, Allen N, Travis R, Roddam A, Jenab M . Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2007; 86(3):672-81. DOI: 10.1093/ajcn/86.3.672. View

10.

Fleshner N, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K . Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol. 2011; 29(17):2386-90. DOI: 10.1200/JCO.2010.32.0994. View

11.

Fulgoni 3rd V, Keast D, Bailey R, Dwyer J . Foods, fortificants, and supplements: Where do Americans get their nutrients?. J Nutr. 2011; 141(10):1847-54. PMC: 3174857. DOI: 10.3945/jn.111.142257. View

12.

Shim S, Lee J . Dose-response meta-analysis: application and practice using the R software. Epidemiol Health. 2019; 41:e2019006. PMC: 6635664. DOI: 10.4178/epih.e2019006. View

13.

Weinstein S, Wright M, Lawson K, Snyder K, Mannisto S, Taylor P . Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007; 16(6):1253-9. DOI: 10.1158/1055-9965.EPI-06-1084. View

14.

Lane J, Oliver S, Appleby P, Lentjes M, Emmett P, Kuh D . Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries. Eur J Clin Nutr. 2016; 71(2):274-283. PMC: 5215092. DOI: 10.1038/ejcn.2016.162. View

15.

Rawla P . Epidemiology of Prostate Cancer. World J Oncol. 2019; 10(2):63-89. PMC: 6497009. DOI: 10.14740/wjon1191. View

16.

Ramon J, Bou R, Romea S, Alkiza M, Jacas M, Ribes J . Dietary fat intake and prostate cancer risk: a case-control study in Spain. Cancer Causes Control. 2000; 11(8):679-85. DOI: 10.1023/a:1008924116552. View

17.

Brigelius-Flohe R, Kelly F, Salonen J, Neuzil J, Zingg J, Azzi A . The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr. 2002; 76(4):703-16. DOI: 10.1093/ajcn/76.4.703. View

18.

Heinonen O, Albanes D, Virtamo J, Taylor P, HUTTUNEN J, Hartman A . Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998; 90(6):440-6. DOI: 10.1093/jnci/90.6.440. View

19.

Kirsh V, Hayes R, Mayne S, Chatterjee N, Subar A, Dixon L . Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 2006; 98(4):245-54. DOI: 10.1093/jnci/djj050. View

20.

Huang H, He Y, Cui X, Goodin S, Wang H, Du Z . Potent inhibitory effect of δ-tocopherol on prostate cancer cells cultured in vitro and grown as xenograft tumors in vivo. J Agric Food Chem. 2014; 62(44):10752-8. PMC: 4334301. DOI: 10.1021/jf504058f. View